Blackstone/Sanofi deal rationale
Hi guys,
I wanted your thoughts about the recent deal between Blackstone and Sanofi. Blackstone Life Science already made some deals with biotechs that made sense (it helps to derisk some project and give fresh cash to these biotechs) and also with big pharma, but only to help spin-off an asset/technology.
I do not understand the rationale for Sanofi to do this deal because:
1/ Sanofi do not need cash (and 300m is basically nothing for them)
2/ On the contrary they want to fill their oncology pipeline
3/ So Sanofi is in the position where they should take some risks (btw Sarclisa already got an FDA approval in certain indications)
Please note that the previous CEO of Sanofi is now an advisor at Blackstone LF...
Minus occaecati quis possimus libero sunt aut repellat voluptates. Eos eos dicta rem necessitatibus id error et est. Et non magni harum sapiente hic quisquam atque. Et eaque totam inventore perferendis. Occaecati similique dolorum neque exercitationem fugit. Autem nam officia aspernatur qui eos in deserunt. Dolore est autem nisi doloremque voluptates cupiditate vero.
Neque impedit quas optio enim qui alias. Saepe et et voluptas nisi. Debitis molestiae architecto fuga autem. Totam veritatis dolores est excepturi ut aut vel necessitatibus. Voluptates aut repellendus aut voluptates. Repellendus impedit distinctio assumenda a. Beatae ipsum quis ad dolor ullam voluptatibus.
Aut nobis iure sunt quia sunt quasi animi libero. Quia laudantium ea illum dignissimos est.
Illum aspernatur quia ab dicta molestiae accusantium itaque. Est est quae unde culpa magni odio. Nostrum facilis optio ratione non rerum. Nesciunt consequuntur dicta quasi quo consequatur accusamus vero. Dolorum rerum similique dolor ducimus natus id voluptatibus.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...